Cargando…

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study

Background: Systemic immune-inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR) and systemic immune-inflammatory index (SII) are associated with the prognosis of many cardiovascular and neoplastic diseases. Moyamoy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Liu, Chenglong, Yu, Xiaofan, Zhai, Yuanren, He, Qiheng, Li, Junsheng, Liu, Xingju, Ye, Xun, Zhang, Qian, Wang, Rong, Zhang, Yan, Ge, Peicong, Zhang, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591523/ https://www.ncbi.nlm.nih.gov/pubmed/37865806 http://dx.doi.org/10.1080/07853890.2023.2269368

Ejemplares similares

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
por: Liu, Chenglong, et al.
Publicado: (2023)

Association of circulating branched-chain amino acids with risk of moyamoya disease
por: Zeng, Chaofan, et al.
Publicado: (2022)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
por: Yu, Xiaofan, et al.
Publicado: (2023)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2023)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Integrated analysis of the association between methionine cycle and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Circulating choline pathway nutrients and risk of moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2022)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2020)

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
por: Ge, Peicong, et al.
Publicado: (2020)

Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation
por: Ge, Peicong, et al.
Publicado: (2020)

Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
por: Zhang, Shaosen, et al.
Publicado: (2022)

Corrigendum: Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
por: Zhang, Shaosen, et al.
Publicado: (2023)

Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion
por: Li, Jiaxi, et al.
Publicado: (2019)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

Clinical Significance of Ultrasound-Based Hemodynamic Assessment of Extracranial Internal Carotid Artery and Posterior Cerebral Artery in Symptomatic and Angiographic Evolution of Moyamoya Disease: A Preliminary Study
por: Zheng, Shuai, et al.
Publicado: (2021)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
por: Deng, Xiaofeng, et al.
Publicado: (2021)

Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study
por: Liu, Wei, et al.
Publicado: (2023)

Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm
por: Yang, Ri-Miao, et al.
Publicado: (2023)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease
por: Zhao, Jinbing, et al.
Publicado: (2022)

High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm
por: Ge, Peicong, et al.
Publicado: (2022)

Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya
por: Zheng, Jun, et al.
Publicado: (2019)

Investigation of Altered Spontaneous Brain Activities in Patients With Moyamoya Disease Using Percent Amplitude of Fluctuation Method: A Resting-State Functional MRI Study
por: Li, Chu-Qi, et al.
Publicado: (2021)

Clinical use of color Doppler ultrasonography to predict and evaluate the collateral development of two common revascularizations in patients with moyamoya disease
por: Wang, Jing-Zhe, et al.
Publicado: (2022)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
por: Zhang, Xin, et al.
Publicado: (2022)

Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6jjvltaejtm554kfuqo2tfrrl1